70 related articles for article (PubMed ID: 8975336)
1. [Occurrence of primary hypothyroidism in alpha-interferon treatment].
Saglietti G; Ferrari V; Luraschi A; Ripamonti G; Gioria A; Fedeli P; Bersi M
Recenti Prog Med; 1996; 87(7-8):342-5. PubMed ID: 8975336
[TBL] [Abstract][Full Text] [Related]
2. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
3. Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
Silvestri F; Virgolini L; Mazzolini A; Bertolissi F; Russo D; Fanin R; Baccarani M
Haematologica; 1994; 79(4):367-70. PubMed ID: 7806093
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated complications during interferon alpha therapy in chronic myelogenous leukemia.
Tóthová E; Kafková A; Stecová N; Fricová M; Guman T; Svorcová E
Neoplasma; 2002; 49(2):91-4. PubMed ID: 12088112
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].
Eugène C; Tennenbaum R; Anciaux ML; Quevauvilliers J; Bergue A
Gastroenterol Clin Biol; 1993; 17(8-9):594-7. PubMed ID: 8253318
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.
Dumoulin FL; Leifeld L; Sauerbruch T; Spengler U
Biomed Pharmacother; 1999 Jun; 53(5-6):242-54. PubMed ID: 10424246
[TBL] [Abstract][Full Text] [Related]
7. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
Weissel M; Templ E; Gisslinger H
Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
9. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
[TBL] [Abstract][Full Text] [Related]
10. [Transient thyroid dysfunction during chronic viral hepatitis treated with alpha-interferon].
Luboshitzky R; Ayash A; Nussinson E
Harefuah; 1995 Jan; 128(2):85-7, 127. PubMed ID: 7721181
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid function abnormalities during interferon therapy].
Tsukada K; Nomura T; Higashi K; Takeuchi T
Nihon Rinsho; 1994 Jul; 52(7):1895-900. PubMed ID: 8078204
[TBL] [Abstract][Full Text] [Related]
13. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hemolytic anemia during alpha interferon treatment in nine patients with hematological diseases.
Andriani A; Bibas M; Callea V; De Renzo A; Chiurazzi F; Marcenò R; Musto P; Rotoli B
Haematologica; 1996; 81(3):258-60. PubMed ID: 8767532
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2].
Steegmann JL; Granados E; Vázquez L; de la Cámara R; Peñarrubia MJ; Fernández-Contreras E; Quiroga JA; Fernández Rañada JM
Sangre (Barc); 1998 Oct; 43(5):443-6. PubMed ID: 9868341
[TBL] [Abstract][Full Text] [Related]
17. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
[TBL] [Abstract][Full Text] [Related]
18. Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha.
Jones TH; Wadler S; Hupart KH
Semin Oncol; 1998 Feb; 25(1 Suppl 1):54-63. PubMed ID: 9482541
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma].
Umemoto S; Izumi K; Kanno H
Hinyokika Kiyo; 2007 Apr; 53(4):225-9. PubMed ID: 17515071
[TBL] [Abstract][Full Text] [Related]
20. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
